These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9638391)

  • 1. The ELITE Study. What are its implications for the drug treatment of heart failure? Evaluation of Losartan in the Elderly Study.
    Aronow WS
    Drugs Aging; 1998 Jun; 12(6):423-8. PubMed ID: 9638391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New competition in the realm of renin-angiotensin axis inhibition; the angiotensin II receptor antagonists in congestive heart failure.
    Martineau P; Goulet J
    Ann Pharmacother; 2001 Jan; 35(1):71-84. PubMed ID: 11197588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II receptor antagonists in heart failure: rationale and design of the evaluation of losartan in the elderly (ELITE) trial.
    Pitt B; Chang P; Timmermans PB
    Cardiovasc Drugs Ther; 1995 Oct; 9(5):693-700. PubMed ID: 8573552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Losartan: a review of its use, with special focus on elderly patients.
    Simpson KL; McClellan KJ
    Drugs Aging; 2000 Mar; 16(3):227-50. PubMed ID: 10803861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.
    Pitt B; Poole-Wilson PA; Segal R; Martinez FA; Dickstein K; Camm AJ; Konstam MA; Riegger G; Klinger GH; Neaton J; Sharma D; Thiyagarajan B
    Lancet; 2000 May; 355(9215):1582-7. PubMed ID: 10821361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Angiotensin receptor antagonist for therapy of patients with hypertension].
    Rakugi H; Ogihara T
    Nihon Rinsho; 1997 Aug; 55(8):2075-80. PubMed ID: 9284426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II receptor antagonists. Potential in elderly patients with cardiovascular disease.
    Burrell LM; Johnston CI
    Drugs Aging; 1997 Jun; 10(6):421-34. PubMed ID: 9205848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE).
    Pitt B; Segal R; Martinez FA; Meurers G; Cowley AJ; Thomas I; Deedwania PC; Ney DE; Snavely DB; Chang PI
    Lancet; 1997 Mar; 349(9054):747-52. PubMed ID: 9074572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study--ELITE II.
    Pitt B; Poole-Wilson P; Segal R; Martinez FA; Dickstein K; Camm AJ; Konstam MA; Riegger G; Klinger GH; Neaton J; Sharma D; Thiyagarajan B
    J Card Fail; 1999 Jun; 5(2):146-54. PubMed ID: 10404354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy.
    Konstam MA; Patten RD; Thomas I; Ramahi T; La Bresh K; Goldman S; Lewis W; Gradman A; Self KS; Bittner V; Rand W; Kinan D; Smith JJ; Ford T; Segal R; Udelson JE
    Am Heart J; 2000 Jun; 139(6):1081-7. PubMed ID: 10827391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of angiotensin-converting enzyme inhibition versus angiotensin II receptor blockade on cardiac sympathetic activity in patients with heart failure.
    Azevedo ER; Mak S; Floras JS; Parker JD
    Am J Physiol Regul Integr Comp Physiol; 2017 Oct; 313(4):R410-R417. PubMed ID: 28679681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of long-term treatment with enalapril, losartan and their combination on the quality of life of patients with congestive heart failure].
    Vizir VA; Berezin AE
    Ter Arkh; 2002; 74(1):52-5. PubMed ID: 11878061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The preclinical basis of the therapeutic evaluation of losartan.
    Timmermans PB; Wong PC; Chiu AT; Smith RD
    J Hypertens Suppl; 1995 Jul; 13(1):S1-13. PubMed ID: 18800450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators.
    Lang RM; Elkayam U; Yellen LG; Krauss D; McKelvie RS; Vaughan DE; Ney DE; Makris L; Chang PI
    J Am Coll Cardiol; 1997 Oct; 30(4):983-91. PubMed ID: 9316528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are angiotensin II receptor blockers more efficacious than placebo in heart failure? Implications of ELITE-2. Evaluation of Losartan In The Elderly.
    Berry C; Norrie J; McMurray JJ
    Am J Cardiol; 2001 Mar; 87(5):606-7, A9. PubMed ID: 11230847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudy. Evaluation of Losartan in the Elderly.
    Houghton AR; Harrison M; Cowley AJ
    Eur J Heart Fail; 1999 Dec; 1(4):385-93. PubMed ID: 10937952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporary losartan or captopril in young SHR induces malignant hypertension despite initial normotension.
    Racasan S; Hahnel B; van der Giezen DM; Blezer EL; Goldschmeding R; Braam B; Kriz W; Koomans HA; Joles JA
    Kidney Int; 2004 Feb; 65(2):575-81. PubMed ID: 14717927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of intervention with losartan or captopril in acute myocardial infarction.
    Spinar J; Vitovec J; Spinarova L; Pluhacek L; Fischerova B; Toman J
    Eur J Heart Fail; 2000 Mar; 2(1):91-100. PubMed ID: 10742708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interview with the author of ELITE II. Cave: small studies of fatal illnesses].
    Pitt B
    MMW Fortschr Med; 1999 Nov; 141(47):6. PubMed ID: 10912156
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.